FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
1.360
-0.070 (-4.90%)
At close: Apr 28, 2026, 4:00 PM EDT
1.380
+0.020 (1.47%)
After-hours: Apr 28, 2026, 7:24 PM EDT
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $7.08 million as of April 28, 2026. Its market cap has decreased by -76.90% in one year.
Market Cap
7.08M
Enterprise Value
4.60M
1-Year Change
-76.90%
Ranking
Category
Stock Price
$1.36
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $7.08M, a decrease of -99.25%. That is a compound annual growth rate of -88.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 6.49M | -56.59% |
| Dec 31, 2025 | 14.96M | -78.68% |
| Dec 31, 2024 | 70.17M | -92.58% |
| Jan 31, 2024 | 945.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acurx Pharmaceuticals | 7.27M |
| Immuron | 7.23M |
| Xenetic Biosciences | 6.99M |
| Can-Fite BioPharma | 6.95M |
| Alaunos Therapeutics | 6.56M |
| Akari Therapeutics, | 6.56M |
| XTL Biopharmaceuticals | 6.33M |
| Purple Biotech | 6.23M |